Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


Atlas FT-IR Spectrometer System

Product Description

atlas_ft_ir_system copy.gif

The Atlas FT-IR System is a high performance, automated laboratory reactor with an integrated mid-IR spectrometer. The combination of the Syrris Atlas and Bruker Optics Matrix-MF makes it ideal for real-time analysis of chemical reactions and processes.

The FT-IR Spectrometer is part of Atlas from Syrris, a revolutionary range of modular products, which can form a wide range of lab reactors - designed specifically for research and development chemists. Atlas offers manual or automated control of one or many reactions at a time with volumes from 5 litres to 1ml in jacketed reactors, flasks or vials.

Features & Benefits

Real time, in situ, quantitative analysis: Can be used for analysing product yield, impurities, reaction kinetics, mechanism, end point, etc.

Easy to upgrade: Calorimetry, pH control, gravimetric or volumetric reagent addition, crystallizations, parallel reactions, etc.

Wide temperature and pressure range: -80°C to +180°C and vacuum to 300bar† (†with custom reactors).

Fully automated with integrated analysis: Fully automated reactor control. IR data from the Matrix-MF can be displayed alongside other process data in the Atlas Software.

Wide range of vessel sizes: 50ml, 100ml, 250ml, 500ml, 1L, 2L, 3L* and 5L* (*with remote mount).

Quick change vessel: The oil drain unit, jacketed vessel clamp, auto aligning stirrer and quick oil connectors allow vessels to be changed in under a minute.

Wide wave number range: Analysis is possible from 3,500 to 560cm-1

Easy to use: Twist and click knob, large display and intuitive “drag and drop” software.

Robust: An extremely chemically resistant reactor system and FTIR probe with vibration resistant optics.

Compact: The Atlas footprint of 23cm (9”) square and Matrix-MF footprint of 30cm (12”) square easily fits into fume cupboards.

Product Atlas FT-IR Spectrometer System
Company Syrris Ltd - Product Directory
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Syrris Ltd - Product Directory
Unit 1, Anglian Business Park Orchard Road, Royston Herts SG8 5TW United Kingdom

Tel: +44 (0) 1763 242555
Fax: +44 (0) 1763 242 992
Email: info@syrris.com



Scientific News
Combining Chemotherapy With Immune-Blocking Drug Could Stop Cancer Growing Back
Giving patients a drug that blocks part of the immune system from going into overdrive might help prevent cancer coming back in some people.
Researchers Pioneer Use of Capsules to Save Materials
Wax capsule delivery systems can simplify a wide range of chemistry transformations.
Photoredox Catalyst Unlocks New Pathways for Nickel Chemistry
Using a light-activated catalyst, researchers have unlocked a new pathway in nickel chemistry to construct carbon-oxygen (C-O) bonds that would be highly valuable to pharmaceutical and agrochemical industries.
Scientists Determine How Antibiotic Gains Cancer-Killing Sulfur Atoms
In a discovery with implications for future drug design scientists have shown an unprecedented mechanism for how a natural antibiotic with antitumor properties incorporates sulfur into its molecular structure, an essential ingredient of its antitumor activity.
Familiar Drugs May Block Ebola Virus Infection
A well-known class of molecules, many of which are already in use therapeutically, may be able to block the Ebola virus’s entry into cells and halt the disease in its tracks, according to researchers at the University of Illinois at Chicago.
New Extra ‘Sticky’ Microgel Could Revolutionise Bladder Cancer Treatment
Researchers have designed a new super-efficient way of delivering an anti-cancer drug which could extend and improve the quality of life for bladder cancer patients - and perhaps save lives.
Common Class of ‘Channel Blocking’ Drugs May Find a Role in Cancer Therapy
Discoveries in fruit flies prompt unusual treatment of patient with metastatic disease.
Common Medications Could Delay Brain Injury Recovery
Drugs used to treat common complaints could delay the recovery of brain injury patients according to research by University of East Anglia (UEA) and University of Aberdeen scientists, published today in Brain Injury.
Scientists Make Strides in Therapy Preventing Addiction Relapse
Single Injection of Drug Candidate Prevents Meth Relapse in Animal Models.
New Clot-Busting Treatments Target Number One Killer
Australian researchers funded by the National Heart Foundation are a step closer to a safer and more effective way to treat heart attack and stroke via nanotechnology.

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!